Low-Dose CT Lung Cancer Screening Epoch Medical Imaging, St Ives
Low-dose CT lung cancer screening at Epoch Medical Imaging, St Ives. NLCSP eligible. Early detection for the North Shore — Turramurra, Pymble, Gordon & surrounds.
What Is LDCT Lung Screening and How Does It Detect Lung Cancer Early?
Low-dose CT (LDCT) lung screening is a specialised CT scan designed to detect lung cancer at its earliest stages — when it is most treatable and before symptoms develop. It uses a significantly reduced radiation dose compared to a standard diagnostic chest CT, while still producing high-quality images of the lung tissue.
How LDCT detects early lung cancer:
– The scan produces detailed cross-sectional images of the lungs, allowing radiologists to identify small nodules — areas of abnormal tissue — that are invisible on a standard chest X-ray.
– Most small nodules are benign (non-cancerous), but LDCT can identify the small proportion that represent early-stage cancer when treatment is most effective.
– By detecting cancer before it causes symptoms, LDCT screening gives patients access to treatment at a stage when cure is far more likely.
– The scan takes only a few minutes, requires no injections, and involves no preparation.
LDCT lung screening has now been incorporated into Australia’s National Lung Cancer Screening Program — making it available to eligible Australians at no cost. At Epoch Medical Imaging in St Ives, LDCT lung screening is performed with specialist radiologist reporting and results sent to your GP promptly.
Australia's National Lung Cancer Screening Program (NLCSP) Explained
Australia’s National Lung Cancer Screening Program (NLCSP) was established to bring the proven benefits of LDCT lung screening to eligible Australians at no out-of-pocket cost.
Key facts about the NLCSP:
– The program is based on strong international evidence, including the landmark US National Lung Screening Trial, which demonstrated a 20% reduction in lung cancer mortality with annual LDCT screening in high-risk individuals.
– Eligible participants receive a two-yearly LDCT lung screen at an accredited centre at no cost.
– The program targets individuals aged 50 to 70 with a significant smoking history — the group with the highest risk of lung cancer.
– Scans are reported by specialist radiologists using the Lung-RADS classification system, which standardises how findings are communicated and what follow-up is recommended.
– GP referral is required to access the program.
Epoch Medical Imaging in St Ives participates in LDCT lung screening program, serving patients from St Ives, Turramurra, Pymble, Gordon, Killara, Wahroonga, and across the North Shore. Speak with your GP about whether you are eligible.
LDCT vs Standard Chest CT or Chest X-Ray: What's the Difference?
It is important to understand how LDCT lung screening differs from other chest imaging investigations — they serve very different purposes.
A key point: LDCT is a screening tool for people without symptoms who are at elevated risk. If you have respiratory symptoms such as cough, breathlessness, or chest pain, a diagnostic chest CT — not a screening LDCT — is the appropriate investigation.
LDCT vs Standard Chest CT or Chest X-Ray: What's the Difference?
It is important to understand how LDCT lung screening differs from other chest imaging investigations — they serve very different purposes.
A key point: LDCT is a screening tool for people without symptoms who are at elevated risk. If you have respiratory symptoms such as cough, breathlessness, or chest pain, a diagnostic chest CT — not a screening LDCT — is the appropriate investigation.
How Effective Is Low-Dose CT at Finding Early-Stage Lung Cancer?
The evidence for LDCT lung cancer screening is compelling and has been validated in multiple large international studies.
Key evidence highlights:
– The US National Lung Screening Trial (NLST) — involving over 53,000 participants — demonstrated a 20% reduction in lung cancer mortality and a 6.7% reduction in all-cause mortality with annual LDCT screening compared to chest X-ray.
– The NELSON trial (Netherlands/Belgium) showed a 24% reduction in lung cancer mortality in men and a 33% reduction in women with LDCT screening.
– The majority of lung cancers detected through LDCT screening are found at Stage I or II — the earliest stages, when surgical cure is most likely.
– In contrast, most lung cancers diagnosed after symptoms develop are found at Stage III or IV, when treatment options are more limited.
Early detection through LDCT screening fundamentally changes outcomes for many patients — which is why the NLCSP represents such an important advance in cancer prevention for eligible Australians.
Bulk Billing
Available Here
All Referrals Accepted
We Handle Your
Insurance Claims
We Accept All Workers Compensation Cases
Get in Touch
Have a question or ready to book? Our friendly team is here to help with appointments, referrals and any imaging enquiries you may have.
Working Hours
Monday - Wednesday, Friday 08:00 AM - 05:00 PM
Thursday - 08:00 AM - 07:00 PM
Saturday - 08:30 AM - 1:00 PM